Characterization and development of a Luminex®-based assay for the detection of human IL-23. (September 2010)

• Record Type: Journal Article
• Authors: Rizzi, Giovanni; Zhang, Yan J; Latek, Robert; Weiner, Russell; Rhyne, Paul W
• Is Part Of: Bioanalysis. Volume 2:Number 9(2010)
• Page Start: 1561
• Page End: 1572
• Publication Date: 2010-09
• Subjects: Drugs -- Analysis -- Periodicals; 615.19005
• DOI: 10.4155/bio.10.68
• Languages: English
• ISSNs: 1757-6180

Abstract

Background: IL-23 is a cytokine produced by dendritic cells, T-cells and macrophages that plays a critical regulatory role in the inflammatory and autoimmune responses. We describe the development and preclinical validation of a highly sensitive Luminex ® assay specific to IL-23 that is suitable for its measurement in support of early-phase clinical trials.Results: Intra-assay precision for the BioSource™ ELISA was under 12.3%, and under 5.2% for the eBioscience ® ELISA. In comparison, the Luminex assays provided an intra-assay precision under 6.2%. The measured inter-assay precision was less than 15.6% for the BioSource ELISA, under 33% for the eBioscience and less than 10% for the Luminex assays.Conclusions: The Luminex method described provides a way to measure IL-23 in clinical samples either as a single biomarker or as a panel of biomarkers. The assay should prove useful to scientists and clinicians investigating the biology of IL-23 and to those needing to monitor changes in IL-23 as part of a clinical study.